Enzo Biochem, Inc. (NYSE:ENZ) Short Interest Update

Enzo Biochem, Inc. (NYSE:ENZ) was the recipient of a large decrease in short interest in September. As of September 15th, there was short interest totalling 478,700 shares, a decrease of 5.0% from the August 31st total of 504,000 shares. Currently, 1.3% of the shares of the company are short sold. Based on an average daily volume of 90,600 shares, the short-interest ratio is presently 5.3 days.

Hedge Funds Weigh In On Enzo Biochem

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. XTX Topco Ltd increased its stake in Enzo Biochem by 94.5% in the second quarter. XTX Topco Ltd now owns 28,262 shares of the medical research company’s stock valued at $31,000 after purchasing an additional 13,735 shares in the last quarter. Wittenberg Investment Management Inc. bought a new stake in Enzo Biochem in the 4th quarter valued at about $95,000. Finally, Renaissance Technologies LLC raised its stake in Enzo Biochem by 2.6% during the 2nd quarter. Renaissance Technologies LLC now owns 2,499,546 shares of the medical research company’s stock worth $2,725,000 after buying an additional 64,417 shares during the period. 36.90% of the stock is currently owned by institutional investors and hedge funds.

Enzo Biochem Stock Down 0.9 %

NYSE ENZ traded down $0.01 during trading on Monday, hitting $1.12. 81,334 shares of the company’s stock were exchanged, compared to its average volume of 99,829. The stock’s 50 day moving average price is $1.12 and its two-hundred day moving average price is $1.13. Enzo Biochem has a fifty-two week low of $0.99 and a fifty-two week high of $1.50.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on Enzo Biochem in a report on Saturday. They set a “hold” rating on the stock.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.